Atlas Trials

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Rescuing Patients With Graft Failure

Clinical trial NCT05126186 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05126186
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hematologic DiseasesGraft FailureAllogeneic Hematopoietic Stem Cell Transplantation
Start date
2021-12-01
Primary completion
2025-12-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.